Lehner Anja, Schulze-Neick Ingram, Haas Nikolaus A
Department for Pediatric Cardiology and Intensive Care,Ludwig Maximilians University (LMU),Klinikum der Universität München (KUM),Munich,Germany.
Cardiol Young. 2018 Aug;28(8):1062-1066. doi: 10.1017/S1047951118000720. Epub 2018 Jul 4.
This report describes the first clinical experience with the new Occlutech Atrial Flow Regulator (AFR®) device for implementation of a late Fontan fenestration. The AFR® device secured a defined diameter of the fenestration without spontaneous re-occlusion of this extra-anatomic perforation. This ensured a permanent clinical improvement of our failing Fontan patient.
本报告描述了使用新型Occlutech心房血流调节器(AFR®)装置进行晚期Fontan开窗术的首例临床经验。AFR®装置确保了开窗的特定直径,且该解剖外穿孔不会自发再闭塞。这确保了我们衰竭的Fontan患者的临床状况得到永久性改善。